National Comics Publications, Inc. v. Fawcett Publications, Inc.
National Comics Publications, Inc. v. Fawcett Publications, Inc. was a landmark legal case in the history of comic books and intellectual property law. The case was decided in 1951 and involved a dispute between National Comics Publications, the predecessor of DC Comics, and Fawcett Publications, the publisher of Captain Marvel.
Background[edit | edit source]
National Comics Publications was the publisher of Superman, one of the most popular and influential comic book characters of all time. Fawcett Publications published Captain Marvel, a character who bore some similarities to Superman. National Comics Publications claimed that Captain Marvel was an infringement on their copyright and trademark of Superman.
Legal Proceedings[edit | edit source]
The case was first filed in 1941, but it took a decade to reach a conclusion. National Comics Publications argued that Captain Marvel was a direct copy of Superman, citing similarities in their powers, costumes, and storylines. Fawcett Publications countered that the similarities were superficial and that Captain Marvel was a distinct character.
Court Decision[edit | edit source]
In 1951, the court ruled in favor of National Comics Publications. The court found that Captain Marvel was indeed an infringement on Superman's copyright. As a result, Fawcett Publications was ordered to cease publication of Captain Marvel comics.
Impact[edit | edit source]
The decision had a significant impact on the comic book industry. Fawcett Publications eventually stopped publishing comic books altogether. The case also set a precedent for future intellectual property disputes in the comic book industry.
Related Pages[edit | edit source]
- DC Comics
- Superman (comic book)
- Captain Marvel (DC Comics)
- Copyright
- Trademark
- Intellectual property law
 | This profile of a comics creator, writer, or artist is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
